Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -3699.99% is 4754% below its 5-year average of -76.23%, near the low end of its 5-year range (-3699.99%–-21.92%).
As of the fiscal period ended Tuesday, June 30, 2026. 342.08% below its 12-month average of -836.94%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation.
RETURN ON INVESTED CAPITAL (ROIC)
-3699.99%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-836.94%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-97.24%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-76.23%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
-76.00%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
-342.08%
CURRENT VS 3Y AVG
-3705.10%
CURRENT VS 5Y AVG
-4753.74%
CURRENT VS 10Y AVG
-4768.32%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
8.74%
median of 89 covered companies
CURRENT VS SECTOR MEDIAN
-42433.95%
vs the sector median at left
PDS Biotechnology Corporation
Market Cap
$11.79M
Return on Invested Capital (ROIC)
-3699.99%
TTM Avg
-836.94%
3Y Avg
-97.24%
5Y Avg
-76.23%
Market Cap
$438.82M
Return on Invested Capital (ROIC)
-25.26%
TTM Avg
-29.12%
3Y Avg
-26.65%
5Y Avg
-26.65%
Market Cap
$492.43M
Return on Invested Capital (ROIC)
8.75%
TTM Avg
20.32%
3Y Avg
26.86%
5Y Avg
29.17%
Market Cap
$1.18B
Return on Invested Capital (ROIC)
-7.32%
TTM Avg
-21.18%
3Y Avg
-91.27%
5Y Avg
-61.58%
Market Cap
$2.23B
Return on Invested Capital (ROIC)
10.03%
TTM Avg
-6.49%
3Y Avg
-7.14%
5Y Avg
-3.83%
Market Cap
$3.06B
Return on Invested Capital (ROIC)
5.87%
TTM Avg
7.96%
3Y Avg
-0.22%
5Y Avg
-9.17%
Market Cap
$5.00B
Return on Invested Capital (ROIC)
15.35%
TTM Avg
17.38%
3Y Avg
14.85%
5Y Avg
17.21%
Market Cap
$5.40B
Return on Invested Capital (ROIC)
5.80%
TTM Avg
5.65%
3Y Avg
5.40%
5Y Avg
4.23%
Market Cap
$6.43B
Return on Invested Capital (ROIC)
-4.30%
TTM Avg
9.38%
3Y Avg
-2.79%
5Y Avg
-9.92%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| PDS Biotechnology Corporation (PDSB) | $11.79M | -3699.99% | -836.94% | -97.24% | -76.23% |
| Shoulder Innovations, Inc. (SI)vs › | $438.82M | -25.26% | -29.12% | -26.65% | -26.65% |
| NRC Health (NRC)vs › | $492.43M | 8.75% | 20.32% | 26.86% | 29.17% |
| Teladoc Health, Inc. (TDOC)vs › | $1.18B | -7.32% | -21.18% | -91.27% | -61.58% |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $2.23B | 10.03% | -6.49% | -7.14% | -3.83% |
| TransMedics Group, Inc. (TMDX)vs › | $3.06B | 5.87% | 7.96% | -0.22% | -9.17% |
| Doximity, Inc. (DOCS)vs › | $5.00B | 15.35% | 17.38% | 14.85% | 17.21% |
| Merit Medical Systems, Inc. (MMSI)vs › | $5.40B | 5.80% | 5.65% | 5.40% | 4.23% |
| Hims & Hers Health, Inc. (HIMS)vs › | $6.43B | -4.30% | 9.38% | -2.79% | -9.92% |
| Chemed Corporation (CHE)vs › | $6.84B | 19.48% | 18.99% | 19.98% | 22.15% |
ROIC
-3700.0%
ROE
-372.9%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -3699.99% |
| 2026-03-31 | -146.83% |
| 2025-12-31 | -120.67% |
| 2025-09-30 | -117.73% |
| 2025-06-30 | -99.49% |
| 2025-03-31 | -85.62% |
| 2024-12-31 | -89.08% |
| 2024-09-30 | -84.46% |
| 2024-06-30 | -71.89% |
| 2024-03-31 | -71.40% |
| 2023-12-31 | -86.22% |
| 2023-09-30 | -107.13% |
| 2023-06-30 | -86.34% |
| 2023-03-31 | -66.26% |
| 2022-12-31 | -62.02% |
| 2022-09-30 | -41.65% |
| 2022-06-30 | -56.05% |
| 2022-03-31 | -47.96% |
| 2021-12-31 | -33.79% |
| 2021-09-30 | -28.08% |
| 2021-06-30 | -21.92% |
| 2021-03-31 | -56.05% |
| 2020-12-31 | -53.13% |
| 2020-09-30 | -42.03% |
| 2020-06-30 | -86.52% |
| 2020-03-31 | -83.13% |
| 2019-12-31 | -151.02% |
| 2019-09-30 | -106.01% |
| 2019-06-30 | -71.00% |
| 2019-03-31 | -92.23% |
| 2018-12-31 | -129.64% |
| 2018-09-30 | -171.62% |
| 2018-06-30 | -178.83% |
| 2018-03-31 | -92.47% |
| 2017-12-31 | -62.74% |
| 2017-09-30 | -49.25% |
| 2017-06-30 | -44.18% |
| 2017-03-31 | -45.10% |
| 2016-12-31 | -37.91% |
| 2016-09-30 | -33.34% |
| 2016-06-30 | -32.11% |
| 2016-03-31 | -26.23% |
| 2015-12-31 | -20.74% |
| 2015-09-30 | -41.43% |
| 2015-06-30 | -27.73% |
